JP2023518774A5 - - Google Patents

Info

Publication number
JP2023518774A5
JP2023518774A5 JP2022556468A JP2022556468A JP2023518774A5 JP 2023518774 A5 JP2023518774 A5 JP 2023518774A5 JP 2022556468 A JP2022556468 A JP 2022556468A JP 2022556468 A JP2022556468 A JP 2022556468A JP 2023518774 A5 JP2023518774 A5 JP 2023518774A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
halogenated
membered
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022556468A
Other languages
English (en)
Japanese (ja)
Other versions
JP7654008B2 (ja
JP2023518774A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/081126 external-priority patent/WO2021185256A1/zh
Publication of JP2023518774A publication Critical patent/JP2023518774A/ja
Publication of JP2023518774A5 publication Critical patent/JP2023518774A5/ja
Application granted granted Critical
Publication of JP7654008B2 publication Critical patent/JP7654008B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022556468A 2020-03-16 2021-03-16 置換ピリミジンまたはピリジルアミン誘導体、その組成物及び医薬的使用 Active JP7654008B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202010183457 2020-03-16
CN202010183457.6 2020-03-16
CN202011279917 2020-11-16
CN202011279917.1 2020-11-16
PCT/CN2021/081126 WO2021185256A1 (zh) 2020-03-16 2021-03-16 取代的嘧啶或吡啶胺衍生物、其组合物及医药上的用途

Publications (3)

Publication Number Publication Date
JP2023518774A JP2023518774A (ja) 2023-05-08
JP2023518774A5 true JP2023518774A5 (https=) 2024-06-24
JP7654008B2 JP7654008B2 (ja) 2025-03-31

Family

ID=77770127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022556468A Active JP7654008B2 (ja) 2020-03-16 2021-03-16 置換ピリミジンまたはピリジルアミン誘導体、その組成物及び医薬的使用

Country Status (8)

Country Link
US (1) US20230145793A1 (https=)
EP (1) EP4122927A4 (https=)
JP (1) JP7654008B2 (https=)
KR (1) KR20220147124A (https=)
CN (2) CN118373808A (https=)
AU (1) AU2021239135B2 (https=)
CA (1) CA3171774C (https=)
WO (1) WO2021185256A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022007376A (es) 2019-12-20 2022-09-02 Tenaya Therapeutics Inc Fluoroalqull-oxadiazoles y sus usos.
WO2022166796A1 (zh) * 2021-02-05 2022-08-11 上海齐鲁制药研究中心有限公司 嘧啶或吡啶并杂环类腺苷受体抑制剂及其制备方法和用途
US20240252502A1 (en) 2021-05-04 2024-08-01 Tenaya Therapeutics, Inc. Hdac6 inhibitors for treatment of metabolic disease and hfpef
EP4337202A4 (en) 2021-06-18 2025-04-02 Aligos Therapeutics, Inc. METHODS AND COMPOSITIONS FOR TARGETING PD-L1
WO2023040876A1 (zh) * 2021-09-15 2023-03-23 上海海雁医药科技有限公司 氮杂芳环类化合物及其药学上可接受的盐的多晶型物、药物组合物和应用
AU2022347682B2 (en) * 2021-09-15 2025-08-28 Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Polymorph and application of pyrimidine derivative and pharmaceutically acceptable salt thereof
CN116063292A (zh) * 2021-10-29 2023-05-05 山东晶源生物医药有限公司 一种含氮化合物、其中间体、其组合物、其制备方法及其应用
EP4448512A4 (en) 2021-12-16 2025-11-19 Aligos Therapeutics Inc METHODS AND COMPOSITIONS FOR TARGETING PD-L1
JP2025512384A (ja) 2022-04-13 2025-04-17 ギリアード サイエンシーズ, インコーポレイテッド Trop-2発現がんを治療するための併用療法
JP2024005443A (ja) * 2022-06-30 2024-01-17 ユニマテック株式会社 塩素化された含フッ素ピリミジン化合物の製造方法
JP2024005442A (ja) * 2022-06-30 2024-01-17 ユニマテック株式会社 塩素化された含フッ素ピリミジン化合物の製造方法
WO2025137640A1 (en) 2023-12-22 2025-06-26 Gilead Sciences, Inc. Azaspiro wrn inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI330183B (https=) * 2001-10-22 2010-09-11 Eisai R&D Man Co Ltd
JP2005298449A (ja) * 2004-04-15 2005-10-27 Astellas Pharma Inc 4−アミノピリミジン誘導体
AR070127A1 (es) * 2008-01-11 2010-03-17 Novartis Ag Pirrolo - pirimidinas y pirrolo -piridinas
ES2365960B1 (es) * 2010-03-31 2012-06-04 Palobiofarma, S.L Nuevos antagonistas de los receptores de adenosina.
WO2013124246A1 (de) * 2012-02-22 2013-08-29 Bayer Intellectual Property Gmbh Herbizid wirksame 4-dialkoxymethyl-2-phenylpyrimidine
WO2015091531A1 (en) * 2013-12-19 2015-06-25 Almirall, S.A. Imidazolopyrimidin-2-yl derivatives as jak inhibitors
WO2017088755A1 (en) * 2015-11-23 2017-06-01 Suzhou Yunxuan Yiyao Keji Youxian Gongsi Aminopyrimidine heterocyclic compound with adenosine receptor antagonistic activity
HUE064141T2 (hu) * 2017-01-20 2024-02-28 Arcus Biosciences Inc Azolopirimidin rákkal összefüggõ rendellenességek kezelésére
CN109651358B (zh) * 2017-10-11 2023-04-07 上海迪诺医药科技有限公司 4-氨基吡啶衍生物、其药物组合物、制备方法及应用

Similar Documents

Publication Publication Date Title
JP2023518774A5 (https=)
JP2022507020A5 (https=)
JP2023011052A (ja) オクタヒドロ縮合アザデカリン糖質コルチコイドレセプター調節因子
JP2022552445A5 (https=)
RU2019142795A (ru) Производное n-(азаарил)циклолактам-1-карбоксамида, метод его получения и его применение
RU2018127360A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
JP2021518366A5 (https=)
JP2013522292A5 (https=)
JP2013518881A5 (https=)
RU2004138787A (ru) Тиофенамидины, фармацевтическая композиция (варианты) и способ лечения симптомов нарушения, опосредованного каскадом реакций классического пути комплемента (варианты)
JP2011511095A5 (https=)
JP2022507474A5 (https=)
RU2005136368A (ru) Производные пиперазина и их применение для лечения неврологических и психиатрических заболеваний
EA023826B1 (ru) Дигидропиримидинизохинолиноны и содержащие их фармацевтические композиции для лечения воспалительных нарушений
JP2019516700A5 (https=)
JP2008528466A5 (https=)
CN110770233A (zh) 稠合双环类化合物及其在药物中的应用
RU2018130703A (ru) Новое соединение 2,3,5-замещенного тиофена в качестве ингибитора протеинкиназы
JP2023544404A5 (https=)
JP2019527215A5 (https=)
JP2010538091A5 (https=)
JP2021521243A5 (https=)
JP2019532092A5 (https=)
JP2021500335A5 (https=)
JP2019500374A5 (https=)